Zydis® Bio Technology, Grazax® & Grastek®: Revolutionizing Allergy Therapy
ALK-Abelló is a global research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. Before ALK-Abelló partnered with Catalent, all marketed allergen immunotherapies were delivered by injection, resulting in a limited patient population and reduced patient adherence. Catalent worked with the client to apply Zydis® Fast Dissolve Technology to their therapy, bringing a vastly superior product to market. The overall result was a marked improvement in patient tolerability, preference and compliance. This new technology has allowed ALKAbelló to deliver on their promise to improve the quality of life for allergy patients.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.